版本:
中国

BRIEF-Cipla says UK unit sells stake in Chase Pharmaceuticals

Nov 23 Cipla Ltd

* Cipla EU divests stake in Chase Pharmaceuticals to Allergan

* Allergan has agreed to pay $125 million upfront plus potential regulatory and commercial milestones of up to $875 million to the shareholders of Chase

* Chase's lead alzheimer's dementia drug CPC-201 successfully completed phase 2 and is ready for further clinical development Source text: bit.ly/2f5nbJF Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐